MAP Policy Updates

On December 2, 2024, the Department of Public Health (DPH) Medication Administration Program (MAP) released updates to the MAP Policy Manual. MassAbility (formerly known as The Massachusetts Rehabilitation Commission) has been added to the MAP Policy Manual cover, throughout the manual, and to applicable forms. Several policies with corresponding Competency Tools and Forms have been consolidated to include all links to the Tools and Forms onto the same page to reduce scrolling. 

The following sections of the MAP Policy Manual were revised:

• Section 04
• Language added to clarify that MAP Certification Training must be presented as a hybrid model.
• Section 10
• Language added to clarify that an “agreement” verses a “contract” is required with the pharmacy when utilizing multi-dose medication packaging.
• Language added to clarify that any MAP Consultant, verses only the pharmacist, may be contacted to verify if the medication on-hand may be utilized when Exhausting the Current Supply.
• Section 12
• A link was added to access the ‘high-risk Schedule VI’ medication list.
• Language was added recognizing that some programs (e.g., Day Programs) are not operational 24-hours per day/7-days per week (e.g., Monday-Friday only).
• Section 14
• Language was added to reflect additional Service Provider Policies and Site Record Keeping Requirements if a service provider chooses to train MAP Certified staff to administer injectable schedule VI medications as indicated in Section 19.
• Section 19
• Policies and competency evaluation forms were added allowing MAP Certified staff, who meet the specified criteria and are successfully trained, to administer insulin and other schedule VI medications according to the HCP order, via a pharmacy labeled, prefilled auto-injector pen. Please know that sites may continue to utilize licensed staff to administer insulin and are not required to institute this policy; this policy is optional.
• Section 23
• ‘Policy 23-1 Administration of Injectable Medication’ was removed from the policy manual as injectable schedule VI medications are now addressed in section 19.
• Section 23 now contains contact information.

To review these sections in further detail, please use the following link to review the updated MAP Policy Manual: 

https://www.mass.gov/doc/map-policy-manual-final/download

To read through the Guide to identify updates/changes within the manual, please use the following link:

https://www.mass.gov/doc/guide-to-the-map-policy-manual/download

If you have questions about any of the recent policy changes, please contact your Area/Regional MAP Coordinator.

Thank you,

DDS/DMH/DCF/MassAbility MAP Administrators